In recent developments, Roche has featured prominently in the race to develop TIGIT inhibitors for cancer immunotherapy, ...
Ibex Medical Analytics, the global leader in clinical-grade AI-powered pathology, today announced a significant expansion of ...
The Phase 1b trial consisted of 24 patients with Parkinson’s disease, who received twice-weekly dosing of either HER-096 or placebo over a four-week period. The trial’s exploratory biomarker program ...
Protein biomarkers increasingly play a vital role in advancing health research, driving drug development, and improving clinical outcomes. The close connection between protein biomarkers and human ...
Austin, July 21, 2025 (GLOBE NEWSWIRE) -- Cancer Biomarkers Market Size & Growth Analysis: According to SNS Insider, the global Cancer Biomarkers Market was valued at USD 31.09 billion in 2024 and is ...
The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...
To succeed in developing targeted medicines, companies need a biomarker strategy and the expertise to make smart decisions about clinical trial design, assays, technology platforms and collaborative ...
We’re in the midst of a paradigm shift in biomarker science. Once considered exploratory, biomarker signatures have evolved into strategic assets - tools that actively de-risk decision-making across ...
Cancer biomarkers span a broad biological spectrum, including proteins, metabolites, and nucleic acids detectable in samples such as tissue biopsies and blood. 1 At the beginning of a biomarker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback